SCHEMBL101671

SCHEMBL101671

[CH2]C(C)(C)CCCCCC

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.47
GGPS1 O95749 6/20 0.41
FDPS P14324 9/20 0.39
SMPD1 P17405 2/20 0.38
CES2 O00748 1/20 0.38
LPAR1 Q92633 1/20 0.38
LPAR3 Q9UBY5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9204234 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL1972471 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2260854 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL16594701 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2258208 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2254816 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2255900 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2255667 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2259007 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL2259214 1.00 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN claimed
CN-116693479-A BysspinA derivative, preparation method and pharmaceutical application thereof 中国医学科学院药物研究所 2023-09-05 CN claimed
EP-2601166-A1 COSMETIC PREPARATIONS Cognis IP Management GmbH (DE) 2013-06-12 EP claimed
US-20130131188-A1 Cosmetic Preparations COGNIS IP MANAGEMENT GMBH (DE) 2013-05-23 US claimed
CN-103068786-A Cosmetic preparation COGNIS IP MAN GMBH 2013-04-24 CN claimed
EP-2426101-A1 Cosmetic preparations Cognis IP Management GmbH (DE) 2012-03-07 EP claimed
WO-2012016642-A1 COSMETIC PREPARATIONS COGNIS IP MANAGEMENT GMBH (DE) 2012-02-09 WO claimed
CN-1170879-C Fire-retardant resin composition and shaped article made of same ������������ʽ���� 2004-10-13 CN claimed
EP-0667163-A1 POWDER FOR NASAL ADMINISTRATION OF PEPTIDIC OR PROTEINACEOUS DRUG TEIJIN LIMITED (JP) 1995-08-16 EP claimed
CN-115232184-B Ribofuranosylpyridine derivatives, pharmaceutical compositions and uses thereof 宁波熙健医药科技有限公司 2024-07-05 CN disclosed
US-12012475-B2 Method of olefin polymerization using alkane-soluble non-metallocene precatalyst DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-18 US disclosed
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN disclosed
CN-112823163-B Alkane soluble non-metallocene precatalyst 陶氏环球技术有限责任公司 2024-04-19 CN disclosed
CN-113272087-B Security element 巴斯夫欧洲公司 2024-04-19 CN disclosed
US-4137183-A OIL ADDITIVES, FROM DIHYDROCARBYL DITHIOPHOSPHORIC ACIDS AND TITANATE COMPOUNDS STANDARD OIL COMPANY (INDIANA) (US) 1979-01-30 US disclosed
US-4102902-A Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor ELI LILLY AND COMPANY (US) 1978-07-25 US disclosed
US-4088709-A POLYBUTYLENE TEREPHTHALATE, POLYCARBONATE OF BISPHENOL A, ACYCLIC OR CYCLIC PHOSPHITE EASTMAN KODAK COMPANY (US) 1978-05-09 US disclosed
US-4056356-A Polyester fiber EASTMAN KODAK COMPANY (US) 1977-11-01 US disclosed
US-4013795-A INSECTICIDE, MITICIDE, NEMATOCIDE, FUNGICIDE, BACTERICIDE, RODENTICIDE BAYER AKTIENGESELLSCHAFT (DT) 1977-03-22 US disclosed
US-3959213-A TEREPHTHALIC ACID-ISOPHTHALIC ACID-1,4-CYCLOHEXANEDIMETHANOL-POLYOXYETHYLENE GLYCOL EASTMAN KODAK COMPANY (US) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131188-A1 Cosmetic Preparations CYP1B1, CBR1, ACOX3 TSHR 1074/4885THRB 3322/4885GGPS1 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.